Report Detail
Global Geographic Atrophy Treatment Market Growth (Status and Outlook) 2022-2028
- RnM4398777 |
- 15 March, 2022 |
- Global |
- 102 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Geographic Atrophy Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Geographic Atrophy Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Geographic Atrophy Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Geographic Atrophy Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Geographic Atrophy Treatment market, reaching US$ million by the year 2028. As for the Europe Geographic Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Geographic Atrophy Treatment players cover Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, and Hemera Biosciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Geographic Atrophy Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Geographic Atrophy Treatment Market Size 2017-2028
- 2.1.2 Geographic Atrophy Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Geographic Atrophy Treatment Segment by Type
- 2.2.1 Late-stage (Phase III) Treatment
- 2.2.2 Phase II Treatment
- 2.2.3 Phase I Treatment
- 2.2.4 Pre-Clinical Stage Treatment
- 2.3 Geographic Atrophy Treatment Market Size by Type
- 2.3.1 Geographic Atrophy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Geographic Atrophy Treatment Market Size Market Share by Type (2017-2022)
- 2.4 Geographic Atrophy Treatment Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.5 Geographic Atrophy Treatment Market Size by Application
- 2.5.1 Geographic Atrophy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Geographic Atrophy Treatment Market Size Market Share by Application (2017-2022)
3 Geographic Atrophy Treatment Market Size by Player
- 3.1 Geographic Atrophy Treatment Market Size Market Share by Players
- 3.1.1 Global Geographic Atrophy Treatment Revenue by Players (2020-2022)
- 3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2020-2022)
- 3.2 Global Geographic Atrophy Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Geographic Atrophy Treatment by Regions
- 4.1 Geographic Atrophy Treatment Market Size by Regions (2017-2022)
- 4.2 Americas Geographic Atrophy Treatment Market Size Growth (2017-2022)
- 4.3 APAC Geographic Atrophy Treatment Market Size Growth (2017-2022)
- 4.4 Europe Geographic Atrophy Treatment Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Geographic Atrophy Treatment Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Geographic Atrophy Treatment Market Size by Country (2017-2022)
- 5.2 Americas Geographic Atrophy Treatment Market Size by Type (2017-2022)
- 5.3 Americas Geographic Atrophy Treatment Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Geographic Atrophy Treatment Market Size by Region (2017-2022)
- 6.2 APAC Geographic Atrophy Treatment Market Size by Type (2017-2022)
- 6.3 APAC Geographic Atrophy Treatment Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Geographic Atrophy Treatment by Country (2017-2022)
- 7.2 Europe Geographic Atrophy Treatment Market Size by Type (2017-2022)
- 7.3 Europe Geographic Atrophy Treatment Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Geographic Atrophy Treatment by Region (2017-2022)
- 8.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Geographic Atrophy Treatment Market Forecast
- 10.1 Global Geographic Atrophy Treatment Forecast by Regions (2023-2028)
- 10.1.1 Global Geographic Atrophy Treatment Forecast by Regions (2023-2028)
- 10.1.2 Americas Geographic Atrophy Treatment Forecast
- 10.1.3 APAC Geographic Atrophy Treatment Forecast
- 10.1.4 Europe Geographic Atrophy Treatment Forecast
- 10.1.5 Middle East & Africa Geographic Atrophy Treatment Forecast
- 10.2 Americas Geographic Atrophy Treatment Forecast by Country (2023-2028)
- 10.2.1 United States Geographic Atrophy Treatment Market Forecast
- 10.2.2 Canada Geographic Atrophy Treatment Market Forecast
- 10.2.3 Mexico Geographic Atrophy Treatment Market Forecast
- 10.2.4 Brazil Geographic Atrophy Treatment Market Forecast
- 10.3 APAC Geographic Atrophy Treatment Forecast by Region (2023-2028)
- 10.3.1 China Geographic Atrophy Treatment Market Forecast
- 10.3.2 Japan Geographic Atrophy Treatment Market Forecast
- 10.3.3 Korea Geographic Atrophy Treatment Market Forecast
- 10.3.4 Southeast Asia Geographic Atrophy Treatment Market Forecast
- 10.3.5 India Geographic Atrophy Treatment Market Forecast
- 10.3.6 Australia Geographic Atrophy Treatment Market Forecast
- 10.4 Europe Geographic Atrophy Treatment Forecast by Country (2023-2028)
- 10.4.1 Germany Geographic Atrophy Treatment Market Forecast
- 10.4.2 France Geographic Atrophy Treatment Market Forecast
- 10.4.3 UK Geographic Atrophy Treatment Market Forecast
- 10.4.4 Italy Geographic Atrophy Treatment Market Forecast
- 10.4.5 Russia Geographic Atrophy Treatment Market Forecast
- 10.5 Middle East & Africa Geographic Atrophy Treatment Forecast by Region (2023-2028)
- 10.5.1 Egypt Geographic Atrophy Treatment Market Forecast
- 10.5.2 South Africa Geographic Atrophy Treatment Market Forecast
- 10.5.3 Israel Geographic Atrophy Treatment Market Forecast
- 10.5.4 Turkey Geographic Atrophy Treatment Market Forecast
- 10.5.5 GCC Countries Geographic Atrophy Treatment Market Forecast
- 10.6 Global Geographic Atrophy Treatment Forecast by Type (2023-2028)
- 10.7 Global Geographic Atrophy Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Apellis Pharmaceuticals
- 11.1.1 Apellis Pharmaceuticals Company Information
- 11.1.2 Apellis Pharmaceuticals Geographic Atrophy Treatment Product Offered
- 11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Apellis Pharmaceuticals Main Business Overview
- 11.1.5 Apellis Pharmaceuticals Latest Developments
- 11.2 IVERIC bio
- 11.2.1 IVERIC bio Company Information
- 11.2.2 IVERIC bio Geographic Atrophy Treatment Product Offered
- 11.2.3 IVERIC bio Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 IVERIC bio Main Business Overview
- 11.2.5 IVERIC bio Latest Developments
- 11.3 Alkeus Pharmaceuticals
- 11.3.1 Alkeus Pharmaceuticals Company Information
- 11.3.2 Alkeus Pharmaceuticals Geographic Atrophy Treatment Product Offered
- 11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Alkeus Pharmaceuticals Main Business Overview
- 11.3.5 Alkeus Pharmaceuticals Latest Developments
- 11.4 Hemera Biosciences
- 11.4.1 Hemera Biosciences Company Information
- 11.4.2 Hemera Biosciences Geographic Atrophy Treatment Product Offered
- 11.4.3 Hemera Biosciences Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Hemera Biosciences Main Business Overview
- 11.4.5 Hemera Biosciences Latest Developments
- 11.5 Allegro Ophthalmics
- 11.5.1 Allegro Ophthalmics Company Information
- 11.5.2 Allegro Ophthalmics Geographic Atrophy Treatment Product Offered
- 11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Allegro Ophthalmics Main Business Overview
- 11.5.5 Allegro Ophthalmics Latest Developments
- 11.6 Stealth BioTherapeutics
- 11.6.1 Stealth BioTherapeutics Company Information
- 11.6.2 Stealth BioTherapeutics Geographic Atrophy Treatment Product Offered
- 11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Stealth BioTherapeutics Main Business Overview
- 11.6.5 Stealth BioTherapeutics Latest Developments
- 11.7 Gyroscope Therapeutics
- 11.7.1 Gyroscope Therapeutics Company Information
- 11.7.2 Gyroscope Therapeutics Geographic Atrophy Treatment Product Offered
- 11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Gyroscope Therapeutics Main Business Overview
- 11.7.5 Gyroscope Therapeutics Latest Developments
- 11.8 Regenerative Patch Technologies
- 11.8.1 Regenerative Patch Technologies Company Information
- 11.8.2 Regenerative Patch Technologies Geographic Atrophy Treatment Product Offered
- 11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Regenerative Patch Technologies Main Business Overview
- 11.8.5 Regenerative Patch Technologies Latest Developments
- 11.9 Roche Holding AG
- 11.9.1 Roche Holding AG Company Information
- 11.9.2 Roche Holding AG Geographic Atrophy Treatment Product Offered
- 11.9.3 Roche Holding AG Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Roche Holding AG Main Business Overview
- 11.9.5 Roche Holding AG Latest Developments
- 11.10 Gensight Biologics SA
- 11.10.1 Gensight Biologics SA Company Information
- 11.10.2 Gensight Biologics SA Geographic Atrophy Treatment Product Offered
- 11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Gensight Biologics SA Main Business Overview
- 11.10.5 Gensight Biologics SA Latest Developments
- 11.11 NGM Biopharmaceuticals
- 11.11.1 NGM Biopharmaceuticals Company Information
- 11.11.2 NGM Biopharmaceuticals Geographic Atrophy Treatment Product Offered
- 11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 NGM Biopharmaceuticals Main Business Overview
- 11.11.5 NGM Biopharmaceuticals Latest Developments
- 11.12 AstraZeneca
- 11.12.1 AstraZeneca Company Information
- 11.12.2 AstraZeneca Geographic Atrophy Treatment Product Offered
- 11.12.3 AstraZeneca Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 AstraZeneca Main Business Overview
- 11.12.5 AstraZeneca Latest Developments
- 11.13 Lineage Cell Therapeutics
- 11.13.1 Lineage Cell Therapeutics Company Information
- 11.13.2 Lineage Cell Therapeutics Geographic Atrophy Treatment Product Offered
- 11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Lineage Cell Therapeutics Main Business Overview
- 11.13.5 Lineage Cell Therapeutics Latest Developments
- 11.14 Allergan
- 11.14.1 Allergan Company Information
- 11.14.2 Allergan Geographic Atrophy Treatment Product Offered
- 11.14.3 Allergan Geographic Atrophy Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Allergan Main Business Overview
- 11.14.5 Allergan Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Geographic Atrophy Treatment. Industry analysis & Market Report on Geographic Atrophy Treatment is a syndicated market report, published as Global Geographic Atrophy Treatment Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Geographic Atrophy Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
